How can Johnson & Johnson Innovation (JJI) help you reach your goals?  

We are supporting innovation in major life science clusters through the life science incubator, Johnson & Johnson Innovation, JLABS, with the ultimate aim of enabling commercialization of new healthcare solutions for patients.​

We know what you, the innovator, need to get your science to patients. It is because of you that JJI created regional centers that host a diverse team of science and transaction experts whose goal is to find high potential early-stage innovation and, if on strategy and a fit for Johnson & Johnson, create customized deal structures to help accelerate the science to the patient. 

On April 12, hear from JJI leaders as they provide an overview of JJI goals and mission, highlighting how JJI interacts with the entrepreneurial community through JLABS, JJDC, and other JJI initiatives. 

Speakers will also be on hand to meet with a handful of applicants one-on-one after the presentation. The one-on-one application period ends on March 14th. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of one-on-one meetings is not guaranteed as all applications must be approved. 

 

Participating representatives:

Ibraheem Badejo, Sr. Director, New Ventures, Johnson & Johnson Innovation

Dana Deardorff, Sr. Director, New Ventures, Johnson & Johnson Innovation

Stefanie Dhanda, Sr. Director, Consumer Scientific Innovation, Johnson & Johnson Innovation

Nicola La Monica, Sr. Director, Infectious Disease and Vaccines Scientific Innovation, Janssen R&D

Samantha Lifson, Innovation Activation Specialist, Johnson & Johnson Innovation, JLABS

Kuldeep Neote, Sr. Director, New Ventures, Johnson & Johnson Innovation

Bob Radinsky, VP, Oncology Scientific Innovation, Janssen R&D

Eric Schaeffer, Sr. Director, Neuroscience External Innovation, Janssen R&D 

Agenda: 

10:30 a.m. | Registration and Networking
11:00 a.m. | Presentation and Q&A
12:30 p.m. | Networking Lunch
1:00 p.m. | Program Close
1:00-5:00 p.m. | One-on-one Meetings*